COMPANY INFO
Parallel Fluidics is a private manufacturing company founded in 2020 and headquartered in Boston, Massachusetts. Co-founded by CEO Joshua Gomes and COO Andy Harris, the company specializes in microfluidic device manufacturing, providing a platform that accelerates the journey from concept to scalable microfluidic products for scientific teams, enabling rapid iteration and innovation in life science technologies. Parallel Fluidics has approximately 23 employees and operates in the microfluidics and life sciences industry. Their website is https://www.parallelfluidics.com.
Parallel Fluidics is a private manufacturing company founded in 2020 and headquartered in Boston, Massachusetts. Specializing in microfluidic device manufacturing, the company accelerates the journey from concept to scalable microfluidic products, enabling rapid iteration and innovation in life science technologies. Co-founded by CEO Joshua Gomes and COO Andy Harris, Parallel Fluidics employs approximately 23 people and operates primarily within the microfluidics and life sciences sector.
Parallel Fluidics funding has played a crucial role in supporting the company's growth and innovation. Since its founding, Parallel Fluidics has raised a total of $14 million across five funding rounds. The company’s fundraising journey includes a mix of seed rounds and grant funding, reflecting a strategy focused on both equity investment and non-dilutive financing to support research, product development, and commercialization. From initial launch capital and early-stage R&D support to a recent significant boost aimed at scaling hardware and software solutions, Parallel Fluidics has consistently attracted investor interest and government grants to fuel its expansion.
This recent seed round was designed to accelerate microfluidic development, expand hardware and software solutions, and fund the commercialization of the new product MV-2.
This seed funding supported further product development and enabled the company’s initial entry into the market.
Seed funding in this round was used to advance early R&D efforts and validate Parallel Fluidics’s innovative technology.
Allocated for the initial launch of the company and to support team expansion during its foundational phase.
This grant by the National Science Foundation provided prize money to support early-stage research and development activities.
J2 Ventures is a prominent venture capital firm focused on early-stage, high-impact technology companies. As a lead investor in the 2024 seed round, J2 Ventures has been a critical supporter in enabling Parallel Fluidics to scale microfluidic innovation and bring new products to market.
Praxis Venture is an investor focused on supporting cutting-edge scientific and technology startups. As a key investor, Praxis Venture contributes both capital and sector expertise to drive the company’s growth.
The National Science Foundation awarded grant funding to Parallel Fluidics in its formative stages, enabling the company to conduct valuable early research and establish technological feasibility.
A globally recognized venture capital firm, 8VC’s participation in funding rounds provides strategic capital and guidance, helping Parallel Fluidics navigate the scale-up of its life science technologies.
Bantam Group is an investment firm committed to supporting innovation in advanced manufacturing and life sciences. Their investment in Parallel Fluidics aids in expanding the company's technical capabilities and go-to-market efforts.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Parallel Fluidics funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.